Katherine Berger
Patient Advocate Foundation(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Pharmaceutical industry and healthcare, Cancer Treatment and Pharmacology, Social Media in Health Education, Protein Degradation and Inhibitors
Most-Cited Works
- → NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules(2011)258 cited
- → Financial toxicity in hematological malignancies: a systematic review(2022)46 cited
- → Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis(2022)22 cited
- → Rethinking mechanisms of neurotoxicity with BCMA directed therapy(2021)16 cited
- → Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma(2023)11 cited
- → Value in Myeloma Care: Myth or Reality(2022)3 cited
- → Hybrid Slab Systems in High-rises for More Sustainable Design(2020)2 cited
- → Patient Preferences on Clinical Decision-Making in Myeloma: A 747-Patient Survey(2024)2 cited
- → Patient Preferences on Clinical Decision Making in Multiple Myeloma(2025)2 cited
- → Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology(2023)2 cited